Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Newly Diagnosed Acute Myeloid Leukemia With High Risk

Tundra lists 1 Newly Diagnosed Acute Myeloid Leukemia With High Risk clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06810791

HVA vs IA/DA or VA in the Treatment of ND HR-AML

The aim of this study is to evaluate the safety and efficacy of homohartonine combined with venetoclax and azacitidine (HVA) versus intensive chemotherapy (IA/DA) or venetoclax combined with azacitidine (VA) in newly diagnosed high-risk AML patients.

Gender: All

Ages: 18 Years - Any

Updated: 2025-02-06

1 state

Newly Diagnosed Acute Myeloid Leukemia With High Risk